A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate
Stopped early · Phase 2 · Has a placebo group
Conditions studied: Inflammation, Rheumatoid Arthritis
In brief
This trial is conducted in Europe, North America and South America. The aim of this trial is to investigate the clinical efficacy of NNC0109-0012, a human monoclonal antibody, compared to placebo when administered as weekly repeat subcutaneous (under the skin) injections in to patients with active rheumatoid arthritis (RA) with inadequate responses to methotrexate (MTX) while on a stable background of MTX therapy.
Key facts
- Study ID
- NCT01636843
- Run by
- Novo Nordisk A/S
- People needed
- 298
- Starts
- 2012-10-30
- Expected to finish
- 2014-11-10
- Last updated by the study team
- 2018-09-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novo Nordisk Investigational Site — La Mesa, California, United States
- Novo Nordisk Investigational Site — Los Angeles, California, United States
- Novo Nordisk Investigational Site — Placentia, California, United States
- Novo Nordisk Investigational Site — Upland, California, United States
- Novo Nordisk Investigational Site — Palm Harbor, Florida, United States
- Novo Nordisk Investigational Site — Rock Island, Illinois, United States
- Novo Nordisk Investigational Site — Springfield, Illinois, United States
- Novo Nordisk Investigational Site — South Bend, Indiana, United States
- Novo Nordisk Investigational Site — Cedar Rapids, Iowa, United States
- Novo Nordisk Investigational Site — Wichita, Kansas, United States
- Novo Nordisk Investigational Site — Elizabethtown, Kentucky, United States
- Novo Nordisk Investigational Site — Lake Charles, Louisiana, United States
- Novo Nordisk Investigational Site — Hagerstown, Maryland, United States
- Novo Nordisk Investigational Site — St Louis, Missouri, United States
- Novo Nordisk Investigational Site — Kalispell, Montana, United States
- Novo Nordisk Investigational Site — Freehold, New Jersey, United States
- Novo Nordisk Investigational Site — Toms River, New Jersey, United States
- Novo Nordisk Investigational Site — Albuquerque, New Mexico, United States
- Novo Nordisk Investigational Site — Brooklyn, New York, United States
- Novo Nordisk Investigational Site — Lake Success, New York, United States
- Novo Nordisk Investigational Site — Charlotte, North Carolina, United States
- Novo Nordisk Investigational Site — Norman, Oklahoma, United States
- Novo Nordisk Investigational Site — Orangeburg, South Carolina, United States
- Novo Nordisk Investigational Site — Jackson, Tennessee, United States
- Novo Nordisk Investigational Site — Huntington Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.